Nasdaq · CIK 0001932393 · X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS
GE HEALTHCARE TECHNOLOGIES INC.
GEHC chart by TradingView
PRICE HISTORY
LIVE · NASDAQGEHC chart by TradingView
- REVENUE FY2025 ENDED DEC 2025
- $20.6B
- EBITDA
- $3.3B
- FREE CASH FLOW
- $1.5B
- EPS
- $4.55
- GROSS MARGIN
- 39.99%
- ROIC
- 13.12%
Q1 FY26ENDED MAR 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 17 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
17.0x
+23%13.8x26.6x
⤢
P / SALES (TTM)
1.6x
+7%1.4x2.2x
⤢
P / BOOK
3.0x
+8%2.8x5.6x
⤢
EV / EBITDA (TTM)
12.5x
+18%10.6x16.1x
⤢
EV / REVENUE (TTM)
1.9x
+6%1.8x2.5x
⤢
FCF YIELD (TTM)
4.67%
-2.2pp3.72%6.88%
⤢
DIVIDEND YIELD (TTM)
—
+0.0pp0.16%0.16%
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$5.1B
+18%⤢
EBITDA (DERIVED)
$0.7B
+0%⤢
NET INCOME
$0.4B
+0%⤢
EPS (DILUTED)
$0.85
-1%⤢
REVENUE GROWTH YOY
7.41%
-1.0pp-1.21%8.38%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
2.18%
-6.3pp-3.78%19.97%
⤢
RETURN ON CAPITAL
10.30%
-1.6pp10.30%14.09%
⤢
RETURN ON EQUITY (TTM)
17.89%
-2.6pp17.89%28.39%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN38.53%
OPERATING MARGIN10.04%
NET MARGIN7.58%
FCF MARGIN2.18%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$0.1B
-70%⤢
STOCK-BASED COMP
$0.0B
+84%⤢
CAPITAL EXPENDITURE
$0.2B
+78%⤢
SHARES OUTSTANDING
0.46B
+1%⤢
DIVIDEND / SHARE
$0.04
-42%BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
$2.3B
+57%⤢
TOTAL DEBT
$10.1B
+23%⤢
DEBT / EBITDA (TTM)
3.1x
+20%2.6x3.3x
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 94.12%INSIDERS 0.36%OTHER / RETAIL 5.53%1,699 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| Blackrock Inc. | 7.97% | 36.0M | $2.58B | -2.6% |
| Dodge & Cox Inc. | 6.93% | 31.3M | $2.25B | +0.3% |
| Vanguard Capital Management LLC | 6.39% | 28.9M | $2.07B | NEW |
| Capital Research Global Investors | 4.67% | 21.1M | $1.51B | -16.8% |
| State Street Corporation | 4.55% | 20.5M | $1.47B | +2.4% |
| Vanguard Portfolio Management LLC | 4.25% | 19.2M | $1.38B | NEW |
| Invesco Ltd. | 3.83% | 17.3M | $1.24B | +0.4% |
| Harris Associates L.P. | 3.45% | 15.6M | $1.12B | -1.6% |
| Geode Capital Management, LLC | 2.75% | 12.4M | $889.9M | +2.4% |
| Barrow, Hanley Mewhinney & Strauss, LLC | 2.63% | 11.9M | $853.0M | +82.7% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.